TPW 6.05 Clinical Outcomes and Survival Following Endoscopic Ultrasound-Guided Gastroenterostomy for Malignant Gastric Outlet Obstruction

Clicks: 1
ID: 323963
2026
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal

Ranked #392 of 432 articles by views in the british journal of surgery

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 432 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
Abstract Aims Endoscopic ultrasound-guided gastroenterostomy (EUS-GE) is an alternative to duodenal stenting and surgical gastrojejunostomy for malignant gastric outlet obstruction (GOO), aiming to provide durable luminal patency with fewer procedure-related morbidities. This study evaluated clinical outcomes, complications, and survival following EUS-GE in malignant GOO. Methods Data were collected prospectively for consecutive patients undergoing EUS-GE for malignant GOO and analysed retrospectively. Indications included advanced malignant disease causing symptomatic GOO, primarily in a palliative setting, including patients unsuitable for surgery. Demographic data, procedural details, technical success, complications, and length of hospital stay were recorded. Survival status was determined from clinical records, and survival time was analysed using Kaplan–Meier methods. Results Twenty patients were included (median age 75 years; IQR 62–80). All underwent EUS-GE using a 20 mm × 10 mm lumen-apposing metal stent. Nineteen procedures were performed under conscious sedation, and one with propofol. Technical success was achieved in 19/20 patients (95%), with one failure due to early stent maldeployment. Median post-procedure length of stay was 3.5 days (IQR 2–7.5). Thirty-day mortality was 9/20 (45%). Kaplan–Meier estimated survival was 90% at 7 days, 55% at 30 days, and 35% at 90 days. During a total follow-up period of 1441 days, 15 patients died. Conclusions EUS-guided gastroenterostomy demonstrated high technical success, short hospital stay, and low complication rates in malignant GOO. While early mortality reflects advanced disease stage, outcomes align with comparative evidence supporting EUS-GE as a safe and effective alternative to duodenal stenting and surgical gastrojejunostomy in appropriately selected patients.
Reference Key
openalex_W7172484476 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Swarna Kempe Gowda, Nasir Javed, Roderick Prawiradiradja, C V N Cheruvu, Sirisha Hebbar
Journal the british journal of surgery
Year 2026
DOI
10.1093/bjs/znag087.358
URL
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.